The Value of Lactate Dehydrogenase in Predicting Rhabdomyolysis-Induced Acute Renal Failure; a Narrative Review
Archives of Academic Emergency Medicine,
Vol. 9 No. 1 (2021),
1 Dey 2021
,
Page e24
https://doi.org/10.22037/aaem.v9i1.1096
Abstract
Introduction: Determining the diagnostic value of available biomarkers in predicting rhabdomyolysis-induced acute kidney injury (AKI) is a priority. This study aimed to review the current evidence about the value of lactate dehydrogenase (LDH) in this regard.
Methods: In this narrative review, the papers in PubMed, Embase, and web of science were studied. The keywords prognosis, prognoses, prognostic, LDH, rhabdomyolysis, emergency patients, and acute kidney failure or AKI had been selected from MeSH medical dictionary. Related papers written in English and published from November 2007 to December 2020 were selected.
Results: Finally, 14 articles were accepted for analysis. Among the selected articles, four were randomized clinical trials, seven were cross-sectional, and three were case-control studies. The results of the present review showed that abuse of illegal drugs is the most common cause of rhabdomyolysis. AKI is the most serious complication of rhabdomyolysis reported in the studies. These studies have shown a three-fold increase in AKI following drug-induced rhabdomyolysis. The review of the included articles shows that high LDH can predicts AKI, especially in critical and emergency situations such as rhabdomyolysis where there is a risk of death if diagnosed late. These studies show that LDH increases in the presence of renal failure and tissue damage.
Conclusion: Serum LDH is an appropriate and cost-effective prognostic indicator that can be used for risk classification of patients at risk for rhabdomyolysis-induced AKI.
- L-Lactate Dehydrogenase
- Acute Kidney Injury
- Rhabdomyolysis
- Role
- Review
- Clinical Enzyme Tests
How to Cite
References
Zutt R, Van Der Kooi A, Linthorst G, Wanders R, De Visser M. Rhabdomyolysis: review of the literature. Neuromuscular Disorders. 2014;24(8):651-9.
Safari S, Yousefifard M, Hashemi B, Baratloo A, Forouzanfar MM, Rahmati F, et al. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis. Clinical and experimental nephrology. 2016;20(2):153-61.
Packard K, Price P, Hanson A. Antipsychotic use and the risk of rhabdomyolysis. Journal of pharmacy practice. 2014;27(5):501-12.
Omrani H, Najafi I, Bahrami K, Najafi F, Safari S. Acute kidney injury following traumatic rhabdomyolysis in Kermanshah earthquake victims; a cross-sectional study. The American journal of emergency medicine. 2020.
Hosseini M, Safari S, Sharifi A, Amini M, Farokhi FR, Sanadgol H, et al. Wide spectrum of traumatic rhabdomyolysis in earthquake victims. Acta Medica Iranica. 2009:459-64.
Alavi-Moghaddam M, Safari S, Najafi I, Hosseini M. Accuracy of urine dipstick in the detection of patients at risk for crush-induced rhabdomyolysis and acute kidney injury. European Journal of Emergency Medicine. 2012;19(5):329-32.
Duncan SJ, Howden CW. Proton pump inhibitors and risk of rhabdomyolysis. Drug safety. 2017;40(1):61-4.
Mendes P, Robles PG, Mathur S. Statin-induced rhabdomyolysis: a comprehensive review of case reports. Physiotherapy Canada. 2014;66(2):124-32.
Nelson KL, Stenehjem D, Driscoll M, Gilcrease GW. Fatal statin-induced rhabdomyolysis by possible interaction with palbociclib. Frontiers in Oncology. 2017;7:150.
Jin Y, Ye X, Shao L, Lin B, He C, Zhang B, et al. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy. European journal of cancer. 2013;49(7):1619-26.
Li B, Li C, Guo M, Shang S, Li X, Xie P, et al. Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC. OncoTargets and therapy. 2018;11:6287.
Chen Z, Guo Q, Lu T, Lin S, Zong J, Zhan S, et al. Pretreatment serum lactate dehydrogenase level as an independent prognostic factor of nasopharyngeal carcinoma in the intensity-modulated radiation therapy era. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2017;23:437.
Wang Y, Li G, Wan F, Dai B, Ye D. Prognostic value of D‑lactate dehydrogenase in patients with clear cell renal cell carcinoma. Oncology letters. 2018;16(1):866-74.
Karamanos Y. Purification and characterisation of lactate dehydrogenase: an undergraduate biochemistry laboratory experiment. Adv Biochem. 2014;2(1):14-23.
Åkerström B, Rosenlöf L, Hägerwall A, Rutardottir S, Ahlstedt J, Johansson ME, et al. rA1M-035, a Physicochemically improved human recombinant α1-microglobulin, has therapeutic effects in rhabdomyolysis-induced acute kidney injury. Antioxidants & redox signaling. 2019;30(4):489-504.
Qingying F, Liu R, Fagui H, Shan F, Lu M. Clinical analysis in patients with rhabdomyolysis and acute kidney injury caused by intense exercise. Chinese Journal of Postgraduates of Medicine. 2018;41(10):904-8.
Green H, Tobar A, Gafter-Gvili A, Leibovici L, Klein T, Rahamimov R, et al. Serum lactate dehydrogenase is elevated in ischemic acute tubular necrosis but not in acute rejection in kidney transplant patients. Progress in transplantation. 2017;27(1):53-7.
Nara A, Yajima D, Nagasawa S, Abe H, Hoshioka Y, Iwase H. Evaluations of lipid peroxidation and inflammation in short‐term glycerol‐induced acute kidney injury in rats. Clinical and Experimental Pharmacology and Physiology. 2016;43(11):1080-6.
Vikrant S, Jaryal A, Gupta D, Parashar A. Epidemiology and outcome of acute kidney injury due to venomous animals from a subtropical region of India. Clinical toxicology. 2019;57(4):240-5.
Nishimura H, Enokida H, Kawahira S, Kagara I, Hayami H, Nakagawa M. Acute kidney injury and rhabdomyolysis after Protobothrops flavoviridis bite: a retrospective survey of 86 patients in a tertiary care center. The American journal of tropical medicine and hygiene. 2016;94(2):474-9.
Alzahri MS, Mousa SA, Almomen AM, Hasanato RM, Polimeni JM, Racz MJ. Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease. Saudi Journal of Kidney Diseases and Transplantation. 2015;26(6):1161.
Bennett MR, Nehus E, Haffner C, Ma Q, Devarajan P. Pediatric reference ranges for acute kidney injury biomarkers. Pediatric nephrology. 2015;30(4):677-85.
Zager RA, Johnson AC, Becker K. Renal cortical lactate dehydrogenase: a useful, accurate, quantitative marker of in vivo tubular injury and acute renal failure. PloS one. 2013;8(6):e66776.
Ma L, Qiu J, Zhang Y, Qiu T, Wang B, Chen W, et al. Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival. OncoTargets and therapy. 2018;11:2533.
Weide B, Elsässer M, Büttner P, Pflugfelder A, Leiter U, Eigentler T, et al. Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. British journal of cancer. 2012;107(3):422-8.
Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatric nephrology. 2010;25(10):2123-7.
Mohammadi‐Karakani A, Asgharzadeh‐Haghighi S, Ghazi‐Khansari M, Hosseini R. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. Journal of clinical laboratory analysis. 2007;21(6):413-7.
Huang C-C, Lo H-C, Huang H-H, Kao W-F, Yen DH-T, Wang L-M, et al. ED presentations of acute renal infarction. The American journal of emergency medicine. 2007;25(2):164-9.
- Abstract Viewed: 1617 times
- pdf Downloaded: 789 times
